The SURMOUNT-4 trial followed participants for up to 88 weeks and confirmed that the overall safety profile remained consistent with earlier phases, with gastrointestinal events continuing to be mild to moderate and manageable throughout
This confirms that the medication is still actively working, since stopping it leads to weight regain
Elsaid: The ESSENCE trial showed that semaglutide improves liver histology in fibrotic MASH, which is why the FDA approved it for that use
Our job is to give you medically accurate information so you can make confident, informed decisions
Compounded GLP-1 formulations are not FDA-approved, have not been evaluated for safety or efficacy, and are not generic equivalents to commercial products
So by now, you may be asking yourself If thats the case, why does it feel like my metabolism is so low despite having a lot of excess fat in my body